로딩 중…
지수 로딩 중…
Bright Minds Biosciences Inc.
DRUG· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CA
$60.66+1.92%
2026-06-18
Price Chart
Bright Minds Biosciences Inc.+115.18%
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $594M |
| Revenue | $0.00 |
| Net Income | $-20M |
| Total Assets | $224M |
| Net Assets | $222M |
| Value | |
| P/B | 2.68x |
| FCF Yield | -2.42% |
| Profitability | |
| ROE | -8.89% |
| ROA | -8.78% |
| Financial Health | |
| Debt Ratio | 1.24% |
| Total Debt | $58975.00 |
| FCF | $-14M |
| Cash | $222M |
| Current Ratio | 81.48x |
| Performance | |
| 1Y Return | 115.18% |
| 1M Return | -18.62% |
| From 52W High | -50.98% |
| 1Y MDD | -38.36% |
| Trading | |
| Volume | 238,643 shares |
| Trading Value | $14M |
| Per Share | |
| EPS | $-2.56 |
| BPS | $11.50 |